Dooley K L, Beland F A, Bucci T J, Kadlubar F F
Cancer Res. 1984 Mar;44(3):1172-7.
The N-hydroxy derivatives of 1- and 2-naphthylamine (NA) are directly carcinogenic at sites of application. In this study, the carcinogenicity of these two compounds at s.c. injection sites was compared with their relative rates of absorption, with the extent and persistence of their binding to protein, RNA, and DNA in the skin-subcutis, and with acute histopathological changes observed after local application. Male Sprague-Dawley rats were given injections of the N-hydroxy derivatives in the right rear leg at 16 mumol/dose. When administered twice weekly for 12 weeks, N-hydroxy-1-NA caused a 100% incidence (30 of 30) of poorly differentiated sarcomas at the injection site. N-Hydroxy-2-NA administered in a similar manner resulted in a low yield of tumors (7%; 2 of 30). Injection of N-hydroxy-1-NA once weekly for 12 weeks or twice weekly for 6 weeks also induced a high incidence of sarcomas (93 to 97%), but the time to tumor formation was significantly longer (p less than 0.0001) than in animals treated twice weekly for 12 weeks. The tumors were classified as malignant fibrous histiocytomas. Possible antagonistic or synergistic effects between the two compounds were also investigated. A sequential 6-week treatment with each of the N-hydroxy derivatives did not alter the expected tumor yields. However, alternating injections over 12 weeks caused a significant lengthening in the time to tumor formation (p less than 0.05). N-Hydroxy-1-NA bound covalently to protein, RNA, and DNA to a much greater extent than did N-hydroxy-2-NA. Protein binding with both derivatives decreased by 80 to 90% by 7 days after treatment. RNA binding in N-hydroxy-1-NA-treated rats markedly decreased, while N-hydroxy-2-NA-bound residues diminished only slightly. During this period, the extent of DNA binding with both derivatives remained fairly constant. When N-hydroxy-2-NA was injected 3 days after N-hydroxy-1-NA, there was a marked reduction in the apparent levels of N-hydroxy-1-NA bound to RNA and DNA. The greater tumorigenicity of N-hydroxy-1-NA versus N-hydroxy-2-NA correlated with its greater extent of macromolecular binding. Examination of acute histopathological changes occurring after single injections of N-hydroxy-1-NA and/or N-hydroxy-2-NA indicated that both compounds caused extensive necrosis in tissues at the injection site.(ABSTRACT TRUNCATED AT 400 WORDS)
1-萘胺和2-萘胺(NA)的N-羟基衍生物在应用部位具有直接致癌性。在本研究中,比较了这两种化合物在皮下注射部位的致癌性与其相对吸收速率、它们与皮肤-皮下组织中的蛋白质、RNA和DNA结合的程度及持久性,以及局部应用后观察到的急性组织病理学变化。给雄性Sprague-Dawley大鼠右后腿注射16 μmol/剂量的N-羟基衍生物。当每周注射两次,持续12周时,N-羟基-1-NA在注射部位导致低分化肉瘤的发生率为100%(30只中有30只)。以类似方式给予N-羟基-2-NA导致肿瘤发生率较低(7%;30只中有2只)。每周注射一次N-羟基-1-NA,持续12周或每周注射两次,持续6周也诱导了高发生率的肉瘤(93%至97%),但肿瘤形成时间明显长于每周注射两次,持续12周的动物(p<0.0001)。这些肿瘤被分类为恶性纤维组织细胞瘤。还研究了这两种化合物之间可能的拮抗或协同作用。用每种N-羟基衍生物进行连续6周的治疗并未改变预期的肿瘤发生率。然而,在12周内交替注射导致肿瘤形成时间显著延长(p<0.05)。N-羟基-1-NA与蛋白质、RNA和DNA的共价结合程度比N-羟基-2-NA大得多。治疗7天后,两种衍生物与蛋白质的结合减少了80%至90%。N-羟基-1-NA处理的大鼠中RNA结合明显减少,而N-羟基-2-NA结合的残留物仅略有减少。在此期间,两种衍生物与DNA的结合程度保持相当恒定。当在N-羟基-1-NA注射3天后注射N-羟基-2-NA时,与RNA和DNA结合的N-羟基-1-NA的表观水平明显降低。N-羟基-1-NA比N-羟基-2-NA具有更大的致瘤性与其更大程度的大分子结合相关。对单次注射N-羟基-1-NA和/或N-羟基-2-NA后发生的急性组织病理学变化的检查表明,两种化合物均导致注射部位组织广泛坏死。(摘要截于400字)